Lactobacillus helveticus suppresses experimental rheumatoid arthritis by reducing inflammatory T cell responses

Journal of Functional Foods

Volumn 13, Issue , 2015, Pages 350-362

  Kim, Jung Eun ^a,b   Chae, Chang Suk ^b   Kim, Gi Cheon ^a,b   Hwang, Won ^a,b   Hwang, Ji sun ^b   Hwang, Sung Min ^b   Kim, Young ^c   Ahn, Young Tae ^d   Park, Sung Gyoo ^a   Jun, Chang Duk ^a   Rudra, Dipayan ^b   Im, Sin Hyeog ^b,e  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Institute for Basic Science   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Korea Yakult Co   (South Korea)

^e Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Cytokine; Immune modulation; Inflammation; Probiotics; Rheumatoid arthritis

Indexed keywords

LACTOBACILLUS HELVETICUS;

EID: 84922562059     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.01.002     Document Type: Article

References (58)

1. Bezkorovainy A. Probiotics: Determinants of survival and growth in the gut. The American Journal of Clinical Nutrition 2001, 73:399s-405s.
2. Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., Montori V. Anti-tnf antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA: The Journal of the American Medical Association 2006, 295:2275-2285.
3. Borchers A.T., Selmi C., Meyers F.J., Keen C.L., Gershwin M.E. Probiotics and immunity. Journal of Gastroenterology 2009, 44:26-46.
4. Brand D., Latham K., Rosloniec E. Collagen-induced arthritis. Nature Protocols 2007, 2:1269-1275.
5. Brennan F.M., McInnes I.B. Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation 2008, 118:3537-3545.
6. Chae C.-S., Kwon H.-K., Hwang J.-S., Kim J.-E., Im S.-H. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis. PLoS ONE 2012, 7:e52119.
7. Cho Y.-G., Cho M.-L., Min S.-Y., Kim H.-Y. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmunity Reviews 2007, 7:65-70.
8. Christensen H.R., Larsen C.N., Kæstel P., Rosholm L.B., Sternberg C., Michaelsen K.F., Frøkiær H. Immunomodulating potential of supplementation with probiotics: A dose-response study in healthy young adults. FEMS Immunology and Medical Microbiology 2006, 47:380-390.
9. Cooper A.M., Khader S.A. IL-12p40: An inherently agonistic cytokine. Trends in Immunology 2007, 28:33-38.
10. Feldmann M., Maini R.N. Anti-TNFα therapy of rheumatoid arthritis: What have we learned?. Annual Review of Immunology 2001, 19:163-196.
11. Fiorentino D.F., Zlotnik A., Mosmann T., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. The Journal of Immunology 1991, 147:3815-3822.
12. Foligne B., Nutten S., Grangette C., Dennin V., Goudercourt D., Poiret S., Dewulf J., Brassart D., Mercenier A., Pot B. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology 2007, 13:236-243.
13. Foligne B., Zoumpopoulou G., Dewulf J., Ben Younes A., Chareyre F., Sirard J.-C., Pot B., Grangette C. A key role of dendritic cells in probiotic functionality. PLoS ONE 2007, 2:e313.
14. Frece J., Kos B., Svetec I.K., Zgaga Z., Beganović J., Leboš A., Šušković J. Synbiotic effect of Lactobacillus helveticus M92 and prebiotics on the intestinal microflora and immune system of mice. The Journal of Dairy Research 2009, 76:98-104.
15. Guarner F. The intestinal flora in inflammatory bowel disease: Normal or abnormal?. Current Opinion in Gastroenterology 2005, 21:414-418.
16. Heijtz R.D., Wang S., Anuar F., Qian Y., Björkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(7):3047-3052.
17. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature Reviews. Immunology 2010, 10:159-169.
18. Iida N., Dzutsev A., Stewart C.A., Smith L., Bouladoux N., Weingarten R.A., Molina D.A., Salcedo R., Back T., Cramer S., Dai R.-M., Kiu H., Cardone M., Naik S., Patri A.K., Wang E., Marincola F.M., Frank K.M., Belkaid Y., Trinchieri G., Goldszmid R.S. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013, 342:967-970.
19. Isolauri E., Sütas Y., Kankaanpää P., Arvilommi H., Salminen S. Probiotics: Effects on immunity. The American Journal of Clinical Nutrition 2001, 73:444s-450s.
20. Johansson Å.C., Hansson A.-S., Nandakumar K.S., Bäcklund J., Holmdahl R. IL-10-deficient B10. Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. The Journal of Immunology 2001, 167:3505-3512.
21. Joo H.-M., Kim K.-A., Myoung K.-S., Ahn Y.-T., Lee J.-H., Huh C.-S., Han M.J., Kim D.-H. Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-κB activation. International Immunopharmacology 2012, 14:39-46.
22. Joosten L.A., Lubberts E., Durez P., Helsen M., Jacobs M.J., Goldman M., van den Berg W.B. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis and Rheumatism 1997, 40:249-260.
23. Kamada N., Seo S.-U., Chen G.Y., Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews. Immunology 2013, 13:321-335.
24. Kannan K., Ortmann R.A., Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005, 12:167-181.
25. Kato I., Endo-Tanaka K., Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sciences 1998, 63:635-644.
26. Kleerebezem M., Vaughan E.E. Probiotic and gut lactobacilli and bifidobacteria: Molecular approaches to study diversity and activity. Annual Review of Microbiology 2009, 63:269-290.
27. Kwon H.-K., Kim G.-C., Kim Y., Hwang W., Jash A., Sahoo A., Kim J.-E., Nam J.H., Im S.-H. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clinical Immunology: The Official Journal of the Clinical Immunology Society 2013, 146:217-227.
28. Kwon H.-K., Lee C.-G., So J.-S., Chae C.-S., Hwang J.-S., Sahoo A., Nam J.H., Rhee J.H., Hwang K.-C., Im S.-H. Generation of regulatory dendritic cells and CD4+ Foxp3+ Tcells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:2159-2164.
29. Lavasani S., Dzhambazov B., Nouri M., Fåk F., Buske S., Molin G., Thorlacius H., Alenfall J., Jeppsson B., Weström B. A novel probiotic mixture exerts a therapeutic effecton experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 2010, 5:e9009.
30. Leung D.Y.M., Bieber T. Atopic dermatitis. The Lancet 2003, 361:151-160.
31. Lundin A., Bok C.M., Aronsson L., Björkholm B., Gustafsson J.-Å., Pott S., Arulampalam V., Hibberd M., Rafter J., Pettersson S. Gut flora, Toll-like receptors and nuclear receptors: A tripartite communication that tunes innate immunity in large intestine. Cellular Microbiology 2008, 10:1093-1103.
32. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nature Reviews. Immunology 2004, 4:478-485.
33. Madsen K. Probiotics and the immune response. Journal of Clinical Gastroenterology 2006, 40:232-234.
34. Maini R.N., Taylor P.C. Anti-cytokine therapy for rheumatoid arthritis. Annual Review of Medicine 2000, 51:207-229.
35. Martin F.P.J., Wang Y., Sprenger N., Yap I.K., Lundstedt T., Lek P., Rezzi S., Ramadan Z., van Bladeren P., Fay L.B. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Molecular Systems Biology 2008, 4:157.
36. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews. Immunology 2007, 7:429-442.
37. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001, 19:683-765.
38. Nandakumar K.S., Andrén M., Martinsson P., Bajtner E., Hellström S., Holmdahl R., Kleinau S. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcγRIIB. European Journal of Immunology 2003, 33:2269-2277.
39. Nandakumar K.S., Johansson B.P., Björck L., Holmdahl R. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis and Rheumatism 2007, 56:3253-3260.
40. Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-gut microbiota metabolic interactions. Science 2012, 336:1262-1267.
41. Özdemir Ö. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clinical and Experimental Immunology 2010, 160:295-304.
42. Pot C., Apetoh L., Kuchroo V.K. Type 1 regulatory T cells (Tr1) in autoimmunity. Seminars in Immunology 2011, 23:202-208. Elsevier.
43. Ranganathan P., Eisen S., Yokoyama W., McLeod H. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?. Annals of the Rheumatic Diseases 2003, 62:4-9.
44. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. The Journal of Nutrition 2000, 130:396S-402S.
45. Scher J.U., Abramson S.B. The microbiome and rheumatoid arthritis. Nature Reviews. Rheumatology 2011, 7:569-578.
46. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., Zaat B.A., Yazdanbakhsh M., Wierenga E.A., van Kooyk Y. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. The Journal of Allergy and Clinical Immunology 2005, 115:1260-1267.
47. Smolen J., Steiner G. Therapeutic strategies for rheumatoid arthritis. Nature Reviews Drug Discovery 2003, 2:473-488.
48. So J.-S., Kwon H.-K., Lee C.-G., Yi H.-J., Park J.-A., Lim S.-Y., Hwang K.-C., Jeon Y.H., Im S.-H. Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Molecular Immunology 2008, 45:2690-2699.
49. Takai T. Roles of Fc receptors in autoimmunity. Nature Reviews. Immunology 2002, 2:580-592.
50. Tao J., Kamanaka M., Hao J., Hao Z., Jiang X., Craft J.E., Flavell R.A., Wu Z., Hong Z., Zhao L. IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis. Arthritis Research & Therapy 2011, 13:R212.
51. Taverniti V., Guglielmetti S. Health-promoting properties of Lactobacillus helveticus. Frontiers in Microbiology 2012, 3:392.
52. Taverniti V., Stuknyte M., Minuzzo M., Arioli S., De Noni I., Scabiosi C., Cordova Z.M., Junttila I., Hämäläinen S., Turpeinen H. S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity. Applied and Environmental Microbiology 2013, 79:1221-1231.
53. Toh M.-L., Miossec P. The role of T cells in rheumatoid arthritis: New subsets and new targets. Current Opinion in Rheumatology 2007, 19:284-288. 210.1097/BOR.1090b1013e32805e32887e32800.
54. Vaahtovuo J., Munukka E., Korkeamäki M., Luukkainen R., Toivanen P. Fecal microbiota in early rheumatoid arthritis. The Journal of Rheumatology 2008, 35:1500-1505.
55. Vaghef-Mehrabany E., Alipour B., Homayouni-Rad A., Sharif S.-K., Asghari-Jafarabadi M., Zavvari S. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition (Burbank, Los Angeles County, Calif.) 2014, 30:430-435.
56. Viaud S., Saccheri F., Mignot G., Yamazaki T., Daillère R., Hannani D., Enot D.P., Pfirschke C., Engblom C., Pittet M.J., Schlitzer A., Ginhoux F., Apetoh L., Chachaty E., Woerther P.-L., Eberl G., Bérard M., Ecobichon C., Clermont D., Bizet C., Gaboriau-Routhiau V., Cerf-Bensussan N., Opolon P., Yessaad N., Vivier E., Ryffel B., Elson C.O., Doré J., Kroemer G., Lepage P., Boneca I.G., Ghiringhelli F., Zitvogel L. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013, 342:971-976.
57. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., Sitaraman S.V., Knight R., Ley R.E., Gewirtz A.T. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010, 328:228-231.
58. Walmsley M., Katsikis P.D., Abney E., Parry S., Williams R.O., Maini R.N., Feldmann M. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis and Rheumatism 1996, 39:495-503.